{"name":"Scarlata, Simone, M.D.","slug":"scarlata-simone-m-d","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Respiratory","slug":"respiratory","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"anti IL5 receptor antibodies","genericName":"anti IL5 receptor antibodies","slug":"anti-il5-receptor-antibodies","indication":"Eosinophilic asthma","status":"marketed"}]}],"pipeline":[{"name":"anti IL5 receptor antibodies","genericName":"anti IL5 receptor antibodies","slug":"anti-il5-receptor-antibodies","phase":"marketed","mechanism":"Anti-IL-5 receptor antibodies block the interleukin-5 receptor on eosinophils, preventing eosinophil activation and reducing eosinophilic inflammation.","indications":["Eosinophilic asthma","Chronic rhinosinusitis with nasal polyps","Eosinophilic granulomatosis with polyangiitis (EGPA)"],"catalyst":""}],"recentEvents":[],"realNews":[],"patents":[],"drugCount":1,"phaseCounts":{"marketed":1},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}